Skip to main content
. 2020 Dec 3;63:103150. doi: 10.1016/j.ebiom.2020.103150

Fig. 2.

Fig 2

Differential transcription factor activity between normal prostates and primary prostate cancers. (a–e) Activity profiles of transcription factors activated/repressed in primary prostate cancers compared with those in normal prostates. Activity changes are displayed in the rightmost column. (f) Disease ontologies (top three) and (g) KEGG pathways enriched in the altered transcription factors (BH adjusted p-value < 0.05). TF, transcription factor; FC, fold change.